229 related articles for article (PubMed ID: 12898533)
1. Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide.
Penkowa M; Camats J; Hadberg H; Quintana A; Rojas S; Giralt M; Molinero A; Campbell IL; Hidalgo J
J Neurosci Res; 2003 Aug; 73(4):481-96. PubMed ID: 12898533
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
Penkowa M; Quintana A; Carrasco J; Giralt M; Molinero A; Hidalgo J
J Neurosci Res; 2004 Jul; 77(1):35-53. PubMed ID: 15197737
[TBL] [Abstract][Full Text] [Related]
3. IL-6 deficiency leads to reduced metallothionein-I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment.
Penkowa M; Hidalgo J
Exp Neurol; 2000 May; 163(1):72-84. PubMed ID: 10785446
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein-I overexpression alters brain inflammation and stimulates brain repair in transgenic mice with astrocyte-targeted interleukin-6 expression.
Penkowa M; Camats J; Giralt M; Molinero A; Hernández J; Carrasco J; Campbell IL; Hidalgo J
Glia; 2003 May; 42(3):287-306. PubMed ID: 12673834
[TBL] [Abstract][Full Text] [Related]
5. Astrocyte-targeted expression of interleukin-3 and interferon-alpha causes region-specific changes in metallothionein expression in the brain.
Giralt M; Carrasco J; Penkowa M; Morcillo MA; Santamaría J; Campbell IL; Hidalgo J
Exp Neurol; 2001 Apr; 168(2):334-46. PubMed ID: 11259121
[TBL] [Abstract][Full Text] [Related]
6. Metallothioneins are upregulated in symptomatic mice with astrocyte-targeted expression of tumor necrosis factor-alpha.
Carrasco J; Giralt M; Penkowa M; Stalder AK; Campbell IL; Hidalgo J
Exp Neurol; 2000 May; 163(1):46-54. PubMed ID: 10785443
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein-1+2 deficiency increases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin 6.
Giralt M; Penkowa M; Hernández J; Molinero A; Carrasco J; Lago N; Camats J; Campbell IL; Hidalgo J
Neurobiol Dis; 2002 Apr; 9(3):319-38. PubMed ID: 11950277
[TBL] [Abstract][Full Text] [Related]
8. Altered central nervous system cytokine-growth factor expression profiles and angiogenesis in metallothionein-I+II deficient mice.
Penkowa M; Carrasco J; Giralt M; Molinero A; Hernández J; Campbell IL; Hidalgo J
J Cereb Blood Flow Metab; 2000 Aug; 20(8):1174-89. PubMed ID: 10950378
[TBL] [Abstract][Full Text] [Related]
9. Impaired inflammatory response to glial cell death in genetically metallothionein-I- and -II-deficient mice.
Penkowa M; Giralt M; Moos T; Thomsen PS; Hernández J; Hidalgo J
Exp Neurol; 1999 Mar; 156(1):149-64. PubMed ID: 10192786
[TBL] [Abstract][Full Text] [Related]
10. Localization of metallothionein-I and -III expression in the CNS of transgenic mice with astrocyte-targeted expression of interleukin 6.
Carrasco J; Hernandez J; Gonzalez B; Campbell IL; Hidalgo J
Exp Neurol; 1998 Oct; 153(2):184-94. PubMed ID: 9784278
[TBL] [Abstract][Full Text] [Related]
11. Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6.
Samland H; Huitron-Resendiz S; Masliah E; Criado J; Henriksen SJ; Campbell IL
J Neurosci Res; 2003 Jul; 73(2):176-87. PubMed ID: 12836160
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide.
Penkowa M; Giralt M; Camats J; Hidalgo J
J Comp Neurol; 2002 Mar; 444(2):174-89. PubMed ID: 11835189
[TBL] [Abstract][Full Text] [Related]
13. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice.
Penkowa M; Moos T; Carrasco J; Hadberg H; Molinero A; Bluethmann H; Hidalgo J
Glia; 1999 Feb; 25(4):343-57. PubMed ID: 10028917
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures.
Penkowa M; Florit S; Giralt M; Quintana A; Molinero A; Carrasco J; Hidalgo J
J Neurosci Res; 2005 Feb; 79(4):522-34. PubMed ID: 15614785
[TBL] [Abstract][Full Text] [Related]
15. Metallothionein-1+2 protect the CNS after a focal brain injury.
Giralt M; Penkowa M; Lago N; Molinero A; Hidalgo J
Exp Neurol; 2002 Jan; 173(1):114-28. PubMed ID: 11771944
[TBL] [Abstract][Full Text] [Related]
16. M-CSF deficiency leads to reduced metallothioneins I and II expression and increased tissue damage in the brain stem after 6-aminonicotinamide treatment.
Penkowa M; Poulsen C; Carrasco J; Hidalgo J
Exp Neurol; 2002 Aug; 176(2):308-21. PubMed ID: 12359172
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-alpha and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE).
Penkowa M; Hidalgo J
Exp Neurol; 2001 Jul; 170(1):1-14. PubMed ID: 11421579
[TBL] [Abstract][Full Text] [Related]
18. Cyclic GMP phosphodiesterase inhibition alters the glial inflammatory response, reduces oxidative stress and cell death and increases angiogenesis following focal brain injury.
Pifarré P; Prado J; Giralt M; Molinero A; Hidalgo J; Garcia A
J Neurochem; 2010 Feb; 112(3):807-17. PubMed ID: 20002517
[TBL] [Abstract][Full Text] [Related]
19. Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor-beta 1 in astrocytes from distinct brain regions.
Sousa Vde O; Romão L; Neto VM; Gomes FC
Eur J Neurosci; 2004 Apr; 19(7):1721-30. PubMed ID: 15078546
[TBL] [Abstract][Full Text] [Related]
20. Astrocyte-specific overexpression of insulin-like growth factor-I promotes brain overgrowth and glial fibrillary acidic protein expression.
Ye P; Popken GJ; Kemper A; McCarthy K; Popko B; D'Ercole AJ
J Neurosci Res; 2004 Nov; 78(4):472-84. PubMed ID: 15468174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
